Soru

Zorluk: Çok zorGynecologic Oncology

A 56-year-old woman comes to the clinic for a well-woman examination. She feels well and has no current complaints. She experienced menopause at age 51 and denies any hot flashes, vaginal dryness, or postmenopausal bleeding. She takes no medications and has no significant past medical history. Her body mass index is 26 kg/m². Pelvic examination reveals normal external genitalia, a well-estrogenized vagina, and a grossly normal cervix without any visible lesions. A routine cervical cytology test is performed. Three days later, the cytology report indicates that the sample is negative for intraepithelial lesion or malignancy, but it notes the incidental presence of "benign-appearing endometrial cells." Which of the following is the most appropriate next step in management?

  1. A
    Reassurance and continuation of routine screening
  2. B
    Transvaginal ultrasonography
  3. Endometrial biopsyCevap
  4. D
    Colposcopy and endocervical curettage
  5. E
    Serum CA-125 measurement

Cevap

Endometrial biopsy is the mandatory next step to evaluate the uterine lining for hyperplasia or malignancy.
The correct answer is endometrial biopsy. Finding endometrial cells on cervical cytology in any postmenopausal woman, even if they are described as 'benign' and the patient is completely asymptomatic, is an abnormal clinical finding. It carries a significant risk of underlying endometrial hyperplasia or adenocarcinoma. According to established clinical guidelines, the mandatory next step is direct tissue sampling of the endometrium via an office biopsy.

Adım Adım Çözüm

1
Analyze the patient's demographic and clinical presentation.
The patient is a 56-year-old asymptomatic postmenopausal woman.
Menopausal status is the critical determining factor for the management of incidental findings on gynecologic screening tests.
2
Evaluate the results of the cervical cytology.
The test is negative for cervical malignancy but shows benign-appearing endometrial cells.
Identifying all components of the cytology report ensures no clinically significant incidental findings are overlooked.
3
Apply evidence-based diagnostic guidelines for incidental endometrial cells based on menopausal status.
In postmenopausal women, the finding of any endometrial cells on a screening test requires a mandatory endometrial biopsy.
Despite appearing morphologically benign, the mere presence of shed endometrial cells in a postmenopausal woman suggests active endometrial proliferation, which carries a significant risk of underlying hyperplasia or adenocarcinoma.

Anahtar Kavram

The incidental finding of normal or benign-appearing endometrial cells on cervical cytology in any postmenopausal woman requires immediate evaluation with an endometrial biopsy to rule out endometrial carcinoma.
Bu soruyu puanla